Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 38.4B | 44.1B | 36.6B | 33.8B |
Cost of revenue | 2.6B | 5.1B | 6.9B | 6.3B |
Gross profit | 35.8B | 39.0B | 29.7B | 27.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 16.3B | 14.2B | 12.0B | 10.3B |
Operating income | 2.7B | 13.7B | 6.6B | 6.5B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 3.3B | 2.4B | 1.8B | 1.9B |
Other income expense | — | — | — | — |
Pretax income | 9.1B | 8.3B | 11.3B | 8.2B |
Tax provision | 4.4B | 1.3B | 1.5B | 2.6B |
Net income | 4.7B | 7.0B | 9.8B | 5.7B |
Basic EPS | — | 5.0 | 7.1 | 4.1 |
Diluted EPS | — | 5.0 | 7.1 | 4.1 |
Basic average shares | — | 1.3B | 1.3B | 1.4B |
Diluted average shares | — | 1.3B | 1.3B | 1.4B |
EBITDA | 18.2B | 15.2B | 17.3B | 14.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | 135M | -279.4M | -705.8M | -72.7M |
Preferred stock dividends | 0 | 0 | 0 | 0 |